L & S Advisors Inc Immunocore Holdings PLC Transaction History
L & S Advisors Inc
- $771 Million
- Q1 2024
A detailed history of L & S Advisors Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, L & S Advisors Inc holds 20,796 shares of IMCR stock, worth $723,700. This represents 0.18% of its overall portfolio holdings.
Number of Shares
20,796
Previous 20,821
0.12%
Holding current value
$723,700
Previous $1.42 Million
4.99%
% of portfolio
0.18%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding IMCR
# of Institutions
163Shares Held
37.8MCall Options Held
540KPut Options Held
97.3K-
Rtw Investments, LP New York, NY6.02MShares$209 Million6.28% of portfolio
-
Wellington Management Group LLP Boston, MA5.75MShares$200 Million0.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.44MShares$84.8 Million0.02% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.37MShares$82.4 Million4.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY1.79MShares$62.2 Million4.36% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.53B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...